Daniel Thomas O 4
4 · Larimar Therapeutics, Inc. · Filed May 17, 2021
Insider Transaction Report
Form 4
Daniel Thomas O
Director
Transactions
- Award
Stock Option (right to buy)
2021-05-12+8,300→ 8,300 totalExercise: $10.34Exp: 2031-05-12→ Common Stock (8,300 underlying)
Footnotes (1)
- [F1]The Option vests on the earlier of (a) May 12, 2022 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.